Lazard Asset Management »

Atara Biotherapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $999 129 7.75
2024-06-30 $2.0k 308 6.49

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Intercontinen Common Stock (ICE)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Exelon Corp Common Stock (EXC)
Aon Plc/ireland Common Stock (AON)
Exxon Mobil Common Stock (XOM)
Broadcom Common Stock (AVGO)

View all positions for Lazard Asset Management

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Acadian Asset Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Renaissance Technologies
BlackRock
BlackRock
Geode Capital Management
Centiva Capital
Staley Capital Advisers

View all funds holding Atara Biotherapeutics